Antiemetic Therapy in Cancer Patients Submitted to Narcotic Analgesics

  • Fausto Roila
  • Enzo Ballatori
  • Albano Del Favero
Conference paper
Part of the ESO Monographs book series (ESO MONOGRAPHS)

Abstract

Nausea and vomiting are common and familiar side-effects of opioid drugs, but surprisingly few data on the incidence and characteristics of this phenomenon in cancer patients can be found in the literature. In the few studies available the percentage of patients suffering opi-oid-related emesis varied from 2.7% [1] to 40% [2].

Keywords

Dopamine Morphine Serotonin Histamine Dexamethasone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Spector R: Analgesia. In: Spector R (ed) The Scientific Basis of Clinical Pharmacology. Little Brown, Boston 1986 pp 343–354Google Scholar
  2. 2.
    Mitchelson F: Pharmacological agents affecting emesis. A review (part I). Drugs 1992 (43):295–315PubMedGoogle Scholar
  3. 3.
    Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, Rosso R: The incidence of narcotic-induced emesis. J Pain Symptom Management 1991 (6):428–430CrossRefGoogle Scholar
  4. 4.
    Walsh TD: Antiemetic drug combinations in advanced cancer. Lancet 1982 (i):1018CrossRefGoogle Scholar
  5. 5.
    Jaffe JH and Martin WR: Opioid analgesics and antagonists. In: Goodman Gillman A et al (eds) The Pharmacological Basis of Therapeutics. 8th Ed. Pergamon Press, New York 1990 pp 485–521Google Scholar
  6. 6.
    Cousins MJ, Mather LE: Intrathecal and epidural administration of opioids. Anesthesiology 1984 (61): 276–310PubMedCrossRefGoogle Scholar
  7. 7.
    Zenz M, Piepenbrock S, Tryba M: Epidural opiates: long-term experiences in cancer pain. Klin Wochenschr 1985 (63):225–229PubMedCrossRefGoogle Scholar
  8. 8.
    Blancquaert JP, Lefebvre RA, Willems JL: Emetic and antiemetic effects of opioids in the dog. Eur J Pharmacol 1986 (128): 143–150PubMedCrossRefGoogle Scholar
  9. 9.
    Chesselet MF, Chéramy A, Reisine TD, Glowinsky J: Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in the cat caudate nucleus. Nature 1981 (291):320–322PubMedCrossRefGoogle Scholar
  10. 10.
    Gupta YK, Bhandari P, Chugh A, Seth SD, Dixit KS, Bhargava KP: Role of endogenous opioids and histamine in morphine induced emesis. Indian J Exp Biol 1989 (27):52–54PubMedGoogle Scholar
  11. 11.
    Gottlieb A and Luzzani M: II problema della nausea e del vomito da oppiacei nel paziente neoplastico avanzato: nuovo approccio farmacologico con gli antagonisti dei recettori 5-HT3. Studio preliminare. In: Proceedings of the International Congress “II trattamento della nausea e del vomito da chemio-terapia antineoplastica: nuove acquisizioni sul ruolo dei 5-HT3 antagonisti”. Verona, 18 June 1991, pp 127–131Google Scholar
  12. 12.
    Thompson PI, Bingham S, Andrews PLR, Patel N, Joel SP, Slevin ML: Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret. Br J Pharmacol 1992 (106): 3–10PubMedGoogle Scholar
  13. 13.
    Wynn RL, Essien E, Thut PD: The effects of different antiemetic agents on morphine-induced emesis in ferrets. Eur J Pharmacol 1993 (241):47–54PubMedCrossRefGoogle Scholar
  14. 14.
    Costello DJ and Borison HL: Naloxone antagonizes narcotic self-blockade of emesis in the cat. J Pharmacol Exp Ther 1977 (203):222–230PubMedGoogle Scholar
  15. 15.
    Harris AL: Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways. Lancet 1982 (i): 714–716CrossRefGoogle Scholar
  16. 16.
    Osborne RJ, Slevin Ml, Joel SP, Trew DM, Thompson PI, Malpas JS: The analgesic activity and pharmacokinetics of morphine and morphine-6-glucuronide in man. Br J Cancer 1989 (60): 451Google Scholar
  17. 17.
    Hanks GW: Antiemetics for terminal cancer patients. Lancet 1982 (i): 1410CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Fausto Roila
    • 1
  • Enzo Ballatori
    • 2
  • Albano Del Favero
    • 3
  1. 1.Medical Oncology DivisionPoliclinico MontelucePerugiaItaly
  2. 2.Medical Statistics Unit, Department of Internal Medicine and Public HealthUniversity of L’AquilaItaly
  3. 3.Institute of Internal Medicine and Oncological SciencesPoliclinico MontelucePerugiaItaly

Personalised recommendations